Pediatric acute myeloid leukemia co-expressing FLT3/ITD and NUP98/NSD1 treated with gilteritinib plus allogenic peripheral blood stem cell transplantation: A case report

Pediatr Blood Cancer. 2021 Nov;68(11):e29216. doi: 10.1002/pbc.29216. Epub 2021 Jul 10.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aniline Compounds / therapeutic use*
  • Child
  • Histone-Lysine N-Methyltransferase* / genetics
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Mutation
  • Nuclear Pore Complex Proteins* / genetics
  • Peripheral Blood Stem Cell Transplantation*
  • Pyrazines / therapeutic use*
  • fms-Like Tyrosine Kinase 3* / genetics

Substances

  • Aniline Compounds
  • Nuclear Pore Complex Proteins
  • Nup98 protein, human
  • Pyrazines
  • gilteritinib
  • nuclear pore complex protein 98
  • Histone-Lysine N-Methyltransferase
  • NSD1 protein, human
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3

Associated data

  • ClinicalTrials.gov/NCT04240002